4-Hydroxyphenyl Retinamide Preferentially Targets FLT3 Mutated Acute Myeloid Leukemia via ROS Induction and NF-κB Inhibition.
Curr Med Sci
; 40(5): 810-816, 2020 Oct.
Article
in En
| MEDLINE
| ID: mdl-33123895
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tretinoin
/
Leukemia, Myeloid, Acute
/
Protein Kinase Inhibitors
/
Fms-Like Tyrosine Kinase 3
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Curr Med Sci
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: